These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1880217)

  • 21. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal sampling time and clinical implication of the SCN5A promoter haplotype in propafenone therapeutic drug monitoring.
    Doki K; Shirayama Y; Sekiguchi Y; Aonuma K; Kohda Y; Homma M
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1273-1279. PubMed ID: 30116829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.
    Botto GL; Bonini W; Broffoni T; Cappelletti G; Falcone C; Lombardi R; Paulesu A; Pedraglio E; Ferrari G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2114-7. PubMed ID: 7845827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the rate for reaching steady state during oral propafenone therapy in patients with ventricular arrhythmias].
    Dabrowski R; Skrabucha B; Kunicki PK; Kowalik I; Skorykow-Sapińska A; Sitkiewicz D; Sadowski Z
    Pol Arch Med Wewn; 1998 Apr; 99(4):323-30. PubMed ID: 9760820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Propafenone efficacy in preventing supraventricular tachycardia in childhood].
    Bodegas A; Cabrera A; Sarrionaindía MJ; Idígoras G; Rumoroso JR; Pérez García P; Pastor E; Galdeano JM; Sota J; Barrenetxea JI
    Rev Esp Cardiol; 1994 Feb; 47(2):86-91. PubMed ID: 8165353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous propafenone for termination of reentrant supraventricular tachycardia. A placebo-controlled, randomized, double-blind, crossover study.
    Shen EN; Keung E; Huycke E; Dohrmann ML; Nguyen N; Morady F; Sung RJ
    Ann Intern Med; 1986 Nov; 105(5):655-61. PubMed ID: 3767146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral propafenone as treatment for incessant supraventricular and ventricular tachycardia in children.
    Beaufort-Krol GC; Bink-Boelkens MT
    Am J Cardiol; 1993 Nov; 72(15):1213-4. PubMed ID: 8237821
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adenosine triphosphate for supraventricular tachycardia in newborns and suckling infants].
    Haas NA; Pufahl C; König SA; Gessler P; Teufel M
    Dtsch Med Wochenschr; 1994 Oct; 119(40):1351-6. PubMed ID: 7924940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrophysiologic effect of intravenous propafenone in supraventricular tachycardia].
    Iturralde P; Nunura F; Romero L; Colín L; Rosado J; Galván O; de Micheli A; González Hermosillo JA; Casanova JM
    Arch Inst Cardiol Mex; 1991; 61(2):135-41. PubMed ID: 1854228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of atrial ectopic tachycardia in infants < 6 months old.
    Bauersfeld U; Gow RM; Hamilton RM; Izukawa T
    Am Heart J; 1995 Jun; 129(6):1145-8. PubMed ID: 7754946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.
    Capucci A; Boriani G; Marchesini B; Strocchi E; Tomasi L; Balducelli M; Frabetti L; Ambrosioni E; Magnani B
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):281-7. PubMed ID: 2285622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.
    Unal S; Bayrakci B; Yasar U; Karagoz T
    Clin Drug Investig; 2007; 27(7):505-8. PubMed ID: 17563131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clarithromycin on steady-state digoxin concentrations.
    Tanaka H; Matsumoto K; Ueno K; Kodama M; Yoneda K; Katayama Y; Miyatake K
    Ann Pharmacother; 2003 Feb; 37(2):178-81. PubMed ID: 12549942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical value of determination of digoxin concentration in blood during treatment of cardiac insufficiency].
    Naumov VG; Rossel's AN
    Kardiologiia; 1977 Sep; 17(9):34-9. PubMed ID: 926597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.
    Reimold SC; Maisel WH; Antman EM
    Am J Cardiol; 1998 Oct; 82(8A):66N-71N. PubMed ID: 9809903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.
    Bianconi L; Mennuni M
    Am J Cardiol; 1998 Sep; 82(5):584-8. PubMed ID: 9732884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia.
    Morgera T; Dreas L; Humar F; Maras P; Chersevani D; Camerini F
    Int J Cardiol; 1991 May; 31(2):187-97. PubMed ID: 1869328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
    Boutaud P; Guillem JP; Maarek-Charbit M; Amiel A; Ciber M; Herpin D; Demange J
    Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):37-42. PubMed ID: 2930150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.